Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration.

Spooner K, Hong T, Nair R, Chow NCC, Broadhead GK, Wijeyakumar W, Chang AA.

Acta Ophthalmol. 2019 Aug;97(5):e706-e712. doi: 10.1111/aos.14046. Epub 2019 Feb 11.

PMID:
30740921
2.

The burden of neovascular age-related macular degeneration: a patient's perspective.

Spooner KL, Mhlanga CT, Hong TH, Broadhead GK, Chang AA.

Clin Ophthalmol. 2018 Dec 4;12:2483-2491. doi: 10.2147/OPTH.S185052. eCollection 2018.

3.

Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial.

Broadhead GK, Grigg JR, McCluskey P, Hong T, Schlub TE, Chang AA.

Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):31-40. doi: 10.1007/s00417-018-4163-x. Epub 2018 Oct 20.

PMID:
30343354
4.

Orbital fracture with Valsalva manoeuvre causing ciliary artery herniation.

Tang YF, Duncan M, Broadhead GK.

Clin Exp Ophthalmol. 2018 May;46(4):438-439. doi: 10.1111/ceo.13107. Epub 2017 Dec 15. No abstract available.

PMID:
29136318
5.

Guest Editorial: How APAQ Was Born.

Broadhead G.

Adapt Phys Activ Q. 2017 Jul;34(3):209-216. doi: 10.1123/apaq.2017-0053. No abstract available.

PMID:
28727511
6.

Choroidal Thickness and Microperimetry Sensitivity in Age-Related Macular Degeneration.

Broadhead GK, Hong T, McCluskey P, Grigg JR, Schlub TE, Chang AA.

Ophthalmic Res. 2017;58(1):27-34. doi: 10.1159/000464447. Epub 2017 Apr 21.

PMID:
28427081
7.

Bilateral Neovascular Age-Related Macular Degeneration: Comparisons between First and Second Eyes.

Chew JK, Zhu M, Broadhead GK, Luo K, Hong T, Chang AA.

Ophthalmologica. 2017;238(1-2):23-30. doi: 10.1159/000469652. Epub 2017 Apr 11.

PMID:
28395293
8.

Diel rhythms and sex differences in the locomotor activity of hawkmoths.

Broadhead GT, Basu T, von Arx M, Raguso RA.

J Exp Biol. 2017 Apr 15;220(Pt 8):1472-1480. doi: 10.1242/jeb.143966. Epub 2017 Feb 2.

9.

Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration.

Zhu M, Wijeyakumar W, Syed AR, Joachim N, Hong T, Broadhead GK, Li H, Luo K, Chang A.

Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):475-484. doi: 10.1007/s00417-016-3477-9. Epub 2016 Aug 30.

PMID:
27572301
10.

Olfaction in context-sources of nuance in plant-pollinator communication.

Rusch C, Broadhead GT, Raguso RA, Riffell JA.

Curr Opin Insect Sci. 2016 Jun;15:53-60. doi: 10.1016/j.cois.2016.03.007. Epub 2016 Mar 19. Review.

PMID:
27436732
11.

Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome.

Broadhead GK, Grigg JR, McCluskey P, Korsakova M, Chang AA.

Doc Ophthalmol. 2016 Oct;133(2):139-143. Epub 2016 Jul 16.

PMID:
27424008
12.

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.

Chang AA, Broadhead GK, Hong T, Joachim N, Syed A, Schlub TE, Toth L, Peto T, Zhu M.

Ophthalmic Res. 2015;55(2):84-90. doi: 10.1159/000440886. Epub 2015 Dec 5.

PMID:
26637166
13.

Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.

Wong CO, Palmieri M, Li J, Akhmedov D, Chao Y, Broadhead GT, Zhu MX, Berdeaux R, Collins CA, Sardiello M, Venkatachalam K.

Cell Rep. 2015 Sep 29;12(12):2009-20. doi: 10.1016/j.celrep.2015.08.047. Epub 2015 Sep 17.

14.

The role of aflibercept in the management of diabetic macular edema.

Chang AA, Hong T, Ewe SY, Bahrami B, Broadhead GK.

Drug Des Devel Ther. 2015 Aug 6;9:4389-96. doi: 10.2147/DDDT.S62778. eCollection 2015. Review.

15.

Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema.

Chang AA, Li H, Broadhead GK, Luo K, Zhu M.

J Ocul Pharmacol Ther. 2015 Nov;31(9):563-9. doi: 10.1089/jop.2015.0021. Epub 2015 Jul 28.

PMID:
26218262
16.

Dietary modification and supplementation for the treatment of age-related macular degeneration.

Broadhead GK, Grigg JR, Chang AA, McCluskey P.

Nutr Rev. 2015 Jul;73(7):448-62. doi: 10.1093/nutrit/nuv005. Epub 2015 Apr 28. Review.

PMID:
26081455
17.

Efficacy and Safety of Saffron Supplementation: Current Clinical Findings.

Broadhead GK, Chang A, Grigg J, McCluskey P.

Crit Rev Food Sci Nutr. 2016 Dec 9;56(16):2767-76. doi: 10.1080/10408398.2013.879467. Review.

PMID:
25875654
18.

Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration.

Broadhead GK, Hong T, Zhu M, Li H, Schlub TE, Wijeyakumar W, Chang AA.

Retina. 2015 May;35(5):975-81. doi: 10.1097/IAE.0000000000000409.

PMID:
25627086
19.

Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.

Broadhead GK, Chang A.

Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):979-81. doi: 10.1007/s00417-014-2891-0. Epub 2014 Dec 31. No abstract available.

PMID:
25547617
20.

A TRPV channel in Drosophila motor neurons regulates presynaptic resting Ca2+ levels, synapse growth, and synaptic transmission.

Wong CO, Chen K, Lin YQ, Chao Y, Duraine L, Lu Z, Yoon WH, Sullivan JM, Broadhead GT, Sumner CJ, Lloyd TE, Macleod GT, Bellen HJ, Venkatachalam K.

Neuron. 2014 Nov 19;84(4):764-77. doi: 10.1016/j.neuron.2014.09.030. Epub 2014 Oct 30.

21.

Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

Zhu M, Chew JK, Broadhead GK, Luo K, Joachim N, Hong T, Syed A, Chang AA.

Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10.

PMID:
25205618
22.

Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

Broadhead GK, Hong T, Chang AA.

Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Review.

23.

Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy.

Broadhead GK, Chang AA.

Korean J Ophthalmol. 2014 Apr;28(2):189-91. doi: 10.3341/kjo.2014.28.2.189. Epub 2014 Mar 14.

24.

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, Zhu M.

Ophthalmology. 2014 Jan;121(1):188-192. doi: 10.1016/j.ophtha.2013.08.035. Epub 2013 Oct 18.

PMID:
24144450
25.

Choroidal neovascularization in acquired partial lipodystrophy.

Broadhead GK, Chang A.

Eur J Ophthalmol. 2013 May-Jun;23(3):439-41. doi: 10.5301/ejo.5000271. Epub 2013 Mar 6.

PMID:
23483505
26.

Genetics in Age-Related Macular Degeneration: Current Research and Implications for Future Treatment.

Broadhead GK, Chang A, McCluskey P.

Asia Pac J Ophthalmol (Phila). 2012 Sep-Oct;1(5):312-8. doi: 10.1097/APO.0b013e31826e1d4a.

PMID:
26107603
27.

Allosteric modulation of the calcium-sensing receptor by gamma-glutamyl peptides: inhibition of PTH secretion, suppression of intracellular cAMP levels, and a common mechanism of action with L-amino acids.

Broadhead GK, Mun HC, Avlani VA, Jourdon O, Church WB, Christopoulos A, Delbridge L, Conigrave AD.

J Biol Chem. 2011 Mar 18;286(11):8786-97. doi: 10.1074/jbc.M110.149724. Epub 2010 Dec 27.

28.

Characterization of yeast homoserine dehydrogenase, an antifungal target: the invariant histidine 309 is important for enzyme integrity.

Jacques SL, Nieman C, Bareich D, Broadhead G, Kinach R, Honek JF, Wright GD.

Biochim Biophys Acta. 2001 Jan 12;1544(1-2):28-41.

PMID:
11341914
29.
30.

Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs.

Lancaster DL, Adio RA, Tai KK, Simooya OO, Broadhead GD, Tucker GT, Lennard MS.

J Pharm Pharmacol. 1990 Apr;42(4):267-71.

PMID:
1974295
31.

Direct and indirect measurement of the hepatic extraction ratio of indocyanine green in the rat.

Burns E, Ball CE, Christie JP, Broadhead GD, Tucker GT, Bax ND.

Clin Sci (Lond). 1989 May;76(5):503-8.

PMID:
2721117
32.

The use of discriminant analysis in the assessment of deaf children for physical education.

Brunt D, Broadhead GD.

Am Correct Ther J. 1983 Mar-Apr;37(2):43-7. No abstract available.

PMID:
6869156
33.

Factor structure consistency in the Bruininks-Oseretsky Test--short form.

Broadhead GD, Bruininks RH.

Rehabil Lit. 1983 Jan-Feb;44(1-2):13-8. No abstract available.

PMID:
6844704
34.

Discriminant analysis of gross and fine motor proficiency data.

Broadhead GD, Church GE.

Percept Mot Skills. 1982 Oct;55(2):547-52.

PMID:
6218474
35.

Evidence for a novel circulating alpha 1 protein in tumour-bearing rats. Differentiation from acute phase alpha 1 proteins and from alpha 1 fetoprotein.

Hervé F, Urios P, Grigorova AM, Cittanova N, Rondeau Y, Engler R, Broadhead G, Neish W.

Biochem Biophys Res Commun. 1982 Apr 14;105(3):861-8. No abstract available.

PMID:
6178411
36.

Physical education training implications of a Public Law about handicapped children.

Broadhead GD, Brunt D.

Am Correct Ther J. 1982 Jan-Feb;36(1):9-13. No abstract available.

PMID:
6211070
37.

Physical education for previously unserved severely handicapped children.

Broadhead GD.

Rehabil Lit. 1981 Mar-Apr;42(3-4):86-9. No abstract available.

PMID:
6452670
38.

Family characteristics and gross motor traits in handicapped children.

Broadhead GD, Rarick GL.

Res Q. 1978 Dec;49(4):421-9. No abstract available.

PMID:
741079
39.

The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.

Munro DS, Dirmikis SM, Humphries H, Smith T, Broadhead GD.

Br J Obstet Gynaecol. 1978 Nov;85(11):837-43. No abstract available.

PMID:
581471
40.

Curriculum approaches in special education.

Broadhead GD.

Rehabil Lit. 1976 Mar;37(3):71-3, 84. No abstract available.

PMID:
1257588
41.

Bread: a diet for use in the McKenzie bioassay.

Broadhead GD, Dirmikis SM, Humphries H, Justice SK, Loy G, Smith T.

J Endocrinol. 1975 Nov;67(2):309-10. No abstract available.

PMID:
1206284
42.

Dynamometric grip strength in mildly handicapped children.

Broadhead GD.

Rehabil Lit. 1975 Sep;36(9):279-83. No abstract available.

PMID:
1166114
43.

Social class correlates of gross motor performance in special education.

Broadhead GD.

Rehabil Lit. 1974 Nov;35(11):331-5. No abstract available.

PMID:
4417610
44.

Beam walking in special education.

Broadhead GD.

Rehabil Lit. 1974 May;35(5):145-7 passim. No abstract available.

PMID:
4828485
45.

Socioeconomic traits in mildly retarded children of differential diagnosis.

Broadhead GD.

Rehabil Lit. 1973 Apr;34(4):104-7. No abstract available.

PMID:
4693320
46.

The monochloroacetylation of oestrogens prior to gas-liquid chromatography with electron capture detection.

Rajkowski KM, Broadhead GD.

J Chromatogr. 1972 Jul 5;69(2):373-6. No abstract available.

PMID:
5039943
47.

Social class factors in special education.

Broadhead GD.

J Biosoc Sci. 1972 Jul;4(3):315-24. No abstract available.

PMID:
5041263
48.

Gross motor performance in minimally brain injured children.

Broadhead GD.

J Mot Behav. 1972 Jun;4(2):103-11. doi: 10.1080/00222895.1972.10734925.

PMID:
23952558
49.

The physical fitness and motor performance of educable mentally retarded children.

Rarick GL, Widdop JH, Broadhead GD.

Except Child. 1970 Mar;36(7):509-19. No abstract available.

PMID:
5451992
50.

OBSERVATIONS ON THE ANTITHYROID AND GOITROGENIC ACTIVITY OF MILK.

BROADHEAD GD, PEARSON IB, WILSON GM.

J Endocrinol. 1965 Jul;32:353-63. No abstract available.

PMID:
14322057

Supplemental Content

Loading ...
Support Center